The new Medical Device Regulations (2017/745/EU) (MDR), published in May 2017, will replace the existing Medical Devices Directive (93/42/EEC) (MDD) and the Active Implantable Medical Devices...
Recent Posts
Innokas Medical will participate in Nordic Life Science Days (NLSD) event held in Stockholm, Sweden, at the Waterfront congress center on September 10th-12th. Innokas will exhibit at joint stand...
MedTech as a business is changing and getting more complex. For example, the technical complexity and regulatory requirements are something that are increasing as we speak. At the same time there...
Swedish health tech innovator Coala Life AB selected Innokas Medical to manufacture Coala Heart Monitor, which has global market potential.
The software is becoming more and more important part of medical devices in the future. That’s why it is very crucial for the companies working in the field to be able to develop even more complex...
Innokas Medical entered into cooperation agreement with Finnish company GrainSense Oy in 2016. The mutual interest for the companies is to develop a long-term, fruitful co-creation partnership,...
To be able to enter the certain markets with a medical device, it is not enough to have just a good end-product - the development and production processes also have to fulfill certain criteria....
Innokas will participate in two international trade fairs during the coming autumn: in Nordic Life Science Days (NLSD) event held in Stockholm, Sweden in the beginning of September, and in WHINN...
Across industries, the pace to introduce new products is increasing. This puts pressure to shorten the design and development cycles. Medical devices are no exception in this respect.
Healthcare technology is one of the largest high-tech export segments of Finnish industry, and the industry continues to grow strongly. According to the latest export report published by...
